Personal Injury

Xarelto Bleeding Injury Lawsuits

Lieff Cabraser represents patients prescribed Xarelto sold in the U.S. by Janssen Pharmaceuticals, a subsidiary of Johnson and Johnson (“J&J”). Our law firm has been recognized by U.S. News, Best Lawyers, and the National Law Journal as one of the top plaintiffs’ law firms in the nation. Please contact us by completing the contact form below or calling us toll-free at 1 888-321-1510.

Patients charge that Xarelto is a dangerous and defective drug because in certain patients it triggers uncontrolled bleeding and other life-threatening complications.

Contact Lieff Cabraser

contact attorney Paulina do Amaral about your Xarelto caseIf you or a family member have taken Xarelto and suffered a bleeding injury, please use the form below to contact Lieff Cabraser for a prompt and confidential evaluation of your case. There is no charge or obligation to review your case. Or call us toll-free at 1 888-321-1510 and ask to speak to attorney Paulina do Amaral.


First Name (required)

Last Name (required)

Email address (required)

Telephone

Street Address

City

State

Zip

How did you find our site?

Are you currently represented by an attorney?

Please describe your Xarelto injury or issue:

Please sign me up for your Consumer Law newsletter. Yes
Please leave this field empty.


Attorney Wendy Fleishman Speaks on Xarelto Side Effects & Lawsuits

Xarelto was approved in July 2011 to prevent blood clots in patients undergoing knee and hip surgeries, and its use has been expanded to patients with irregular heartbeats or facing a strong likelihood of blood clots in the legs or lungs. It is also used to prevent clots in people who have non-valvular atrial fibrillation. The drug is taken as a pill, and has the chemical name rivaroxaban.

Xarelto Bleeding and Safety Issues

The Xarelto lawsuits allege that the drug can cause major bleeding in the GI tract. Unlike Coumadin, an anti-clotting drug approved over 50 years ago, the concentration of Xarelto in a patient’s blood cannot be reversed in the case of over-dose or other serious complication. Because 95% of rivaroxaban is bound to protein, even emergency dialysis cannot reduce the concentration of Xarelto in a patient’s blood. Only time can do this. If a Xarelto patient has an emergency bleeding event — such as from a severe injury or major brain or GI tract bleeding — the results can be fatal.

Xarelto Lawsuits

The law in most states provides several personal injury claims for persons who have been seriously injured by a prescription drug. In lawsuits against J&J, the complaints have charged that the company failed to adequately warn physicians and patients of the inability to reverse Xarelto’s potentially dangerous thinning of the blood. Damages sought against pharmaceutical companies for dangerous drug side effects and injuries include:

  • Physical pain and suffering, mental anguish and physical impairment;
  • Medical expenses, past and future; and
  • Loss of earnings and/or earning capacity.

In the case of a patient’s death, the family of the victim may file a wrongful death action and seek damages.

Trademark Notice

Xarelto is a registered trademark of Janssen Pharmaceuticals, a subsidiary of Johnson and Johnson. The use of this trademark is solely for product identification and informational purposes. Johnson and Johnson is not affiliated with this website, and Johnson and Johnson has no affiliation with Lieff Cabraser Heimann & Bernstein, LLP. Nothing on this site has been authorized or approved by Johnson and Johnson.